Clinical trial Recruiting at 1 site Observational Ages 65 and up

Intelligent digital health companion for neurocognitive disorders and caregivers

Official title: Talk-to-Jo" Intelligent Digital Health Companion, Neurocognitive Disorders and Dyads: a Qualitative Study

Run by Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal · NCT06606353 · Data updated 2026-11-12

This study is testing a digital health tool called 'Talk-to-Jo' to see if it can help older adults with neurocognitive disorders and their caregivers in Quebec feel better and manage their challenges.

More Caregiver trials

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment40 (estimated)
SponsorCentre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Government
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedDecember 12, 2024
Main results expectedFebruary 2026
Study endsOctober 2026
Registry record updatedFebruary 12, 2025
Trial IDNCT06606353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 65 and older diagnosed with a mild to moderate neurocognitive disorder and living with a caregiver.

Probably not a fit

Patients who are unable to understand spoken and written French or those living in long-term care facilities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the use of an intelligent digital health companion, 'Talk-to-Jo', to support individuals aged 65 and older living with neurocognitive disorders (NCDs) and their caregivers. It aims to address the challenges faced by this population, particularly in Quebec, where access to primary care is often inadequate. The study will evaluate how this digital tool can improve the quality of life for patients and their caregivers by providing timely support and resources. Participants will be recruited from an outpatient clinic and must meet specific eligibility criteria, including language proficiency in French.

Why it matters

Potential benefit: If successful, this study could enhance the quality of life for patients with neurocognitive disorders and their caregivers by providing accessible support and resources.

How similar studies have gone: While the use of digital health companions is a growing field, this specific approach targeting neurocognitive disorders and caregivers is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
1. Person living with an neurocognitive disorder (NCD):

   1. Inclusion criteria:

      * Be 65 years old or older.
      * Have an NCD, whether minor or major, in a mild to moderate stage, diagnosed within the past year.
      * Be receiving care for an NCD at the outpatient clinic of the Montreal Geriatric University Institute.
      * Have a caregiver.
      * Live in a personal residence or in a non-medicalized senior residence.
      * Be able to understand spoken and written French. The "Talk-to-Jo" avatar has only been developed in the French language and can only communicate and understand French.
   2. Exclusion criteria:

      * Inability to provide informed consent for participation in the study.
      * Participating in a concurrent experimental clinical study, to avoid interference with our study.
      * Living in a Long-Term Care Facility or in a medicalized section of an non-medicalized senior residence.
      * Inability to understand spoken and written French.
      * Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
2. Caregiver

   1. Inclusion criteria:

      * Be a caregiver for a person living with an NCD (regardless of the relationship: spouse, child, friend, neighbor, family member).
      * Be able to understand spoken and written French.
   2. Exclusion criteria:

      * Have an NCD.
      * Inability to understand spoken and written French.
      * Participating in a concurrent experimental clinical study, to avoid interference with our study.
      * Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.

Where it's running

  • Criugm
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.